Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years; 2. No gender restriction; 3. Patients with advanced stage IIIB-IV lung cancer confirmed by histopathology or cytology; 4. Subjects voluntarily participate in this study, sign informed consent, have good compliance and cooperate with follow-up; 5. Researchers believe that treatment can be beneficial.
Exclusion criteria
Exclusion criteria: 1. Patients with proven allergy to the test drug and / or its excipients; 2. The subject has an immunodeficiency disease or a history of organ transplantation; 3. Pregnant or lactating women; 4. Patients judged by the researcher as not suitable for inclusion in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Suivival;objective remission rate;Disease control rate;Duration of response;Adverse event; | — |
Countries
China
Contacts
The First Affiliated Hospital of Anhui Medical University